Literature DB >> 18030874

[Acquired haemophilia].

Anna Buczma1, Jerzy Windyga.   

Abstract

Acquired haemophilia (AH) is a severe bleeding diathesis that affects both males and females. It is caused by suddenly appearing autoantibodies that interfere with coagulation factor VIII (FVIII) activity. Although some conditions such as autoimmune diseases, cancer and puerperium seem likely to induce AH, in more than half of the observed cases autoantibodies to FVIII are idiopathic. The clinical picture is characterized by spontaneous and post-traumatic subcutaneous bleeds as well as massive mucosal membrane hemorrhages (from the genitourinary and gastrointestinal tracts). Typical abnormalities in AH are prolonged activated partial thromboplastin time and normal results of the other haemostatic tests (platelet count, prothrombin and thrombin times, fibrinogen concentration). Acquired haemophilia is definitely confirmed by quantification of FVIII neutralizing antibodies. Bleeds are usually treated with activated prothrombin complex concentrates and activated recombinant factor VII. In most patients with AH, the use of immunosuppressive agents results in autoantibody elimination and restoration of normal FVIII plasma activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18030874

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


  8 in total

Review 1.  Rituximab for eradicating inhibitors in people with acquired haemophilia A.

Authors:  Tracey Remmington; Sherie Smith
Journal:  Cochrane Database Syst Rev       Date:  2021-08-23

Review 2.  Acquired hemophilia: a rare but life-threatening potential cause of bleeding in the intensive care unit.

Authors:  Aryeh Shander; Christopher E Walsh; Caroline Cromwell
Journal:  Intensive Care Med       Date:  2011-05-31       Impact factor: 41.787

3.  Acute renal failure as a complication of acquired hemophilia due to autoantibody to factor VIII.

Authors:  Yasuhiro Otaki; Ryo Kouda; Takeo Fujimura; Takeshi Nakatsue; Minako Wakasugi; Shuichi Murakami; Takeshi Kuroda; Ichiei Narita; Masaaki Nakano; Fumitake Gejyo
Journal:  Clin Exp Nephrol       Date:  2009-10-14       Impact factor: 2.801

Review 4.  Interventions for treating acute bleeding episodes in people with acquired hemophilia A.

Authors:  Yan Zeng; Ruiqing Zhou; Xin Duan; Dan Long; Songtao Yang
Journal:  Cochrane Database Syst Rev       Date:  2014-08-28

5.  Could a Haematoma Be Due to an Acquired Phenomenon?

Authors:  Mansoor Zafar; William Butler-Manuel; Joel Newman; Stefano Berliti; Anna Cowley
Journal:  Cureus       Date:  2021-11-21

6.  Report of Two Cases of Acquired Idiopathic Haemophilia.

Authors:  Clara Silva; Mariana Pacheco; João E Silva; Edite Pereira; Jorge S Almeida
Journal:  Cureus       Date:  2021-12-29

7.  Acquired hemophilia A as a cause of recurrent bleeding into the pleural cavity - case report and literature review.

Authors:  Małgorzata Wojtyś; Ewa Żuk; Jacek Alchimowicz; Tomasz Grodzki
Journal:  Kardiochir Torakochirurgia Pol       Date:  2014-09-28

8.  Acquired Factor VIII Inhibitor Presenting as Occult GI Bleeding.

Authors:  Carlos I Pacheco Cano; Marilyn A Arosemena; Roumen B Iordanov; Ankitha Lingamaneni; Ankur Aneja
Journal:  Case Rep Hematol       Date:  2018-06-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.